Anti-CGRP therapies for migraine in multiple sclerosis patients

Salter A Kowalec K Fitzgerald KC , et al. Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial. Neurology 2020; 95(5): e446–e456.

Kudrow D Pascual J Winner PK , et al. Vascular safety of erenumab for migraine prevention. Neurology 2020; 94(5): e497–e510 (Erratum in: Neurology 2020; 94(23): 1052).

Raghavan K Healy BC Carruthers RL , et al. Progression rates and sample size estimates for PPMS based on the CLIMB study population. Mult Scler 2015; 21(2): 180–188.

Waeber C Moskowitz MA . Migraine as an inflammatory disorder. Neurology 2005; 64(10 Suppl. 2): S9–S15.

Rossetti I Zambusi L Finardi A , et al. Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis. J Neuroimmunol 2018; 323: 94–104.